skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Longer TOMM40 poly-T variants associated with higher FDDNP-PET medial temporal tau and amyloid binding

Journal Article · · PLoS ONE
ORCiD logo [1];  [2];  [1];  [1];  [3];  [4];  [1]
  1. Univ. of California, Los Angeles, CA (United States). David Geffen School of Medicine
  2. Univ. of California, Los Angeles, CA (United States); Univ. of Oregon, Eugene, OR (United States)
  3. San Diego State Univ./Univ. of California, San Diego Joint Doctoral Program in Clinical Psychology, CA (United States)
  4. Univ. of California, Los Angeles, CA (United States)

The translocase of outer mitochondrial membrane 40 (TOMM40), which lies in linkage disequilibrium with the apolipoprotein E (APOE) gene, has been implicated in Alzheimer’s disease (AD). TOMM40 influences AD pathology through mitochondrial neurotoxicity, and the medial temporal lobe (MTL) is the most likely brain region for identifying early manifestations of AD-related morphology changes. While early reports indicated that the longer length poly-T allele of TOMM40 increases risk for AD, these findings have not been consistently replicated in further studies. We examined the effect of TOMM40 and APOE on regional brain positron emission tomography (PET) 2-(1-{6-[(2 [F18]fluoroethyl) (methyl) amino]-2-naphthyl}ethylidene)malononitrile (FDDNP) binding values in MTL.A total of 73 non-demented older adults (42 females; mean age: 62.9(10.9) completed genotyping for both APOE and TOMM40 and received FDDNP-PET scans. For TOMM40, the lengths of the poly-T sequence were classified as short (14–20 repeats; S), long (21–29 repeats, L) or very long (>29 repeats, VL). Using general linear models, we examined medial temporal lobe FDDNP binding and cognitive functioning between TOMM40 and APOE-4 groups, with age, sex, and education as covariates. Data from 30 individuals with APOE-4 and L TOMM40 poly-T length, 11 non E4 TOMM40 S/S, 14 non E4 TOMM40 S/VL and 13 non E4 TOMM40 VL/VL were analyzed. Medial temporal FDDNP binding differed significantly between TOMM40/APOE groups (F(3,62) = 3.3,p = .03). Participants with TOMM40 S/S exhibited significantly lower binding compared to TOMM40 S/VL and APOE-4 carriers. We did not find a significant relationship between TOMM40 poly-T lengths/APOE risk groups and cognitive functioning. This is the first report to demonstrate a significant association between longer TOMM40 poly-T lengths and higher medial temporal plaque and tangle burden in non-demented older adults. Identifying biomarkers that are risk factors for AD will enhance our ability to identify subjects likely to benefit from novel AD treatments.

Research Organization:
Univ. of California, San Diego, CA (United States)
Sponsoring Organization:
USDOE Office of Science (SC); Zegar Family Foundation Research Fund; Ahmanson Foundation; McComb Foundation; McMahan Foundation; Bob and Marion Wilson; Fran and Ray Stark Foundation Fund for Alzheimer’s Disease Research; Plott Professorship; Parlow-Solomon Professorship; National Institutes of Health (NIH)
Grant/Contract Number:
FC03-87ER60615; P01-AG025831; AG13308; P50 AG 16570; MH/AG58156; MH52453; AG10123; M01-RR00865
OSTI ID:
1614562
Journal Information:
PLoS ONE, Vol. 13, Issue 12; ISSN 1932-6203
Publisher:
Public Library of ScienceCopyright Statement
Country of Publication:
United States
Language:
English
Citation Metrics:
Cited by: 3 works
Citation information provided by
Web of Science

References (39)

Amyloid imaging of alzheimer’s disease using pittsburgh compound B journal November 2006
The genetic risk of Alzheimer’s disease beyond APOE ε4: systematic review of Alzheimer’s genetic risk scores journal August 2018
Genetic variants specific to aging-related verbal memory: Insights from GWASs in a population-based cohort journal August 2017
Imaging tau and amyloid-β proteinopathies in Alzheimer disease and other conditions journal February 2018
Genetic assessment of age-associated Alzheimer disease risk: Development and validation of a polygenic hazard score journal March 2017
Genome-Wide Association Studies in Alzheimer Disease journal March 2008
An Inherited Variable Poly-T Repeat Genotype in TOMM40 in Alzheimer Disease journal May 2010
Prediction of Cognitive Decline by Positron Emission Tomography of Brain Amyloid and Tau journal February 2012
Comprehensive Search for Alzheimer Disease Susceptibility Loci in the APOE Region journal October 2012
Cerebral amyloid PET imaging in Alzheimer’s disease journal October 2013
High-Yield, Automated Radiosynthesis of 2-(1-{6-[(2-[18F]Fluoroethyl)(methyl)amino]-2-naphthyl}ethylidene)malononitrile ([18F]FDDNP) Ready for Animal or Human Administration journal October 2006
Genome-wide Association Studies in Alzheimer’s Disease: A Review journal August 2013
New Genetic Approaches to AD: Lessons from APOE-TOMM40 Phylogenetics journal April 2016
An Overview of Genome-Wide Association Studies in Alzheimer’s Disease journal January 2016
Apolipoprotein E genotyping by one-stage PCR journal May 1991
Reliability of drawing regions of interest for positron emission tomographic data journal November 1992
The effect of TOMM40 poly-T length on gray matter volume and cognition in middle-aged persons with APOE ɛ3/ɛ3 genotype journal July 2011
Longitudinal modeling of cognitive aging and the TOMM40 effect journal November 2012
Hippocampal thinning linked to longer TOMM40 poly‐T variant lengths in the absence of the APOE ε4 variant journal February 2017
Risk factors associated with the onset and progression of Alzheimer’s disease: A systematic review of the evidence journal July 2017
TOMM40 poly-T repeat lengths, age of onset and psychosis risk in Alzheimer disease journal December 2011
Whole genome association study of brain-wide imaging phenotypes for identifying quantitative trait loci in MCI and AD: A study of the ADNI cohort journal November 2010
Functional analysis of APOE locus genetic variation implicates regional enhancers in the regulation of both TOMM40 and APOE journal November 2011
A TOMM40 variable-length polymorphism predicts the age of late-onset Alzheimer's disease journal December 2009
Serotonin 1A receptors in the living brain of Alzheimer's disease patients journal January 2006
Distribution Volume Ratios without Blood Sampling from Graphical Analysis of PET Data journal September 1996
Localization of Neurofibrillary Tangles and Beta-Amyloid Plaques in the Brains of Living Patients With Alzheimer Disease journal January 2002
The Genetics of Alzheimer Disease journal July 2012
Cliff´s Delta Calculator: A non-parametric effect size program for two groups of observations journal June 2010
Genetic risk factors in Alzheimer's disease journal December 1998
Regional Brain Atrophy Rate Predicts Future Cognitive Decline: 6-year Longitudinal MR Imaging Study of Normal Aging journal December 2003
Cardiovascular risk factors and future risk of Alzheimer’s disease journal November 2014
Vascular risk factors and Alzheimer’s disease journal November 2014
Primum non nocere journal March 2023
Epidemiology and Etiology of Alzheimer’s disease: From Genetic to Non- Genetic Factors journal September 2013
Postmortem 3-D Brain Hemisphere Cortical Tau and Amyloid-β Pathology Mapping and Quantification as a Validation Method of Neuropathology Imaging journal June 2013
Non-familial Alzheimer's disease is mainly due to genetic factors journal July 2002
The Importance of Being Connected journal April 2011
TOMM40 rs10524523 Polymorphism's Role in Late-Onset Alzheimer's Disease and in Longevity journal January 2012